半肝完全血流阻断应用切除右肝巨大血管瘤一例报告

患者,女,32岁.因上腹部不适,B超发现右肝血管瘤渐增大2年余于2008年4月21日入院.查体:肝脏于锁骨中线肋缘下2 cm、剑突下3 cm可触及,边缘锐,质软,无结节.     

肠内免疫微生态营养支持对肝切除患者肝功能的影响

目的探讨肠内营养（EN）和肠内免疫微生态营养（EIN）对肝切除术后患者肝脏功能的影响。方法将82例肝切除患者随机分为两组,手术后分别接受肠内营养和肠内免疫微生态营养1周,观察两种营养方式对患者内毒素、细胞因子及肝功能的影响。结果术前EIN组内毒素、肿瘤坏死因子-α（TNF-α）、白细胞介素-6（IL-6）及肝功能与EN组比较差异无统计学意义（P〉0．05）。营养支持1周后,EIN组内毒素、TNF-α和IL-6分别为（1．88±0．17）pg／ml、（260±28）pg／ml、（158±8）pg／ml,上述指标均较EN组明显下降（P〈0．01或P〈0．05）。EIN组1周后肝功能各项指标与EN组比较差异有统计学意义（P〈0．01或P〈0．05）。结论肠内免疫微生态营养,可以补充肠道正常菌群,减少细菌易位,减少内毒素血症及炎症因子的发生,从而减轻肝切除术后的肝损害。     

腹腔镜下腹腔灌洗引流对重症急性胰腺炎全身炎症反应的影响

目的:探讨腹腔镜下置管腹腔灌洗引流(LPLD)对重症急性胰腺炎(SAP)全身炎症反应的影响.方法:37例SAP患者按入院先后顺序随机分为内科组和LPLD组.检测并比较两组治疗前后0、1、3、7、10 d外周血内毒素、TNF-α、IL-lβ、IL-6的浓度及单核细胞NF-κB的活性.结果:第0天 LPLD组内毒素、TNF-α、IL-lβ、IL-6浓度及单核细胞NF-κB活性与内科组比较无显著差异;术后第10天,LPLD组内毒素、TNF-α、IL-lβ、IL-6浓度及单核细胞NF-κB活性分别为(1.64±0.13)pg/mL、(114.13±15.12)pg/mL、(80.17±18.06)pg/mL、(56.43±12.24)pg/mL、(68.2±1.7)%.上述指标与内科组比较均有显著下降(P<0.01 or P<0.05).结论:LPLD能明显减轻内毒素血症,减低NF-κB活性及细胞因子浓度,有效地减轻SAP患者的炎症反应.     

依达拉奉对肝脏缺血再灌注损伤保护作用的临床研究

目的观察依达拉奉对肝切除术患者肝缺血再灌注损伤的保护作用。方法82例肝切除患者,随机分为对照组（n=40）和试验组（n=42）,试验组给予依达拉奉。分别于术前及术后测定中性粒细胞（PMN）计数、血清谷丙转氨酶（ALT）、谷草转氨酶（AST）含量及肝组织中丙二醛（MDA）及超氧化物岐化酶（SOD）活件。结果肝脏缺血再灌注损伤后,对照组的ALT、AST水平及MDA含量明显高于试验组（P〈0．01或P〈0．05）,SOD活性及PMN计数明显下降（P〈0．05）。结论依达拉奉对肝脏的缺血再灌注损伤有显著的保护作用,其机制可能与减少PMN在肝脏内的聚集进而调节肝组织氧化与抗氧化平衡有关。     

慢性胆囊炎合并下腹疾患的腹腔镜联合手术治疗的体会

1994年 1 0月～ 2 0 0 3年 3月 ,我院应用腹腔镜技术成功为 50例慢性胆囊炎合并下腹疾患实施胆囊、卵巢囊肿、阑尾、宫外孕、子宫肌瘤联合切除术 ,获得满意疗效 ,现报道如下。资料与方法　本组 50例 ,女 46例 ,男 4例年龄 2 4～ 55岁 ,平均 35岁。 8例因慢性结石性胆囊炎入院腹     

肠内免疫微生态营养对全胃切除患者术后免疫功能及治疗效果的影响

目的探讨肠内免疫微生态营养对全胃切除患者免疫功能及临床预后的影响。方法47例全胃切除患者随机分为肠内营养组（EN组）和肠内免疫微生态营养组（EIN组）。比较两组肠内营养支持后1、3、7d外周血T细胞亚群CD4＋、CD8＋及免疫球蛋白IgA、IgG、IgM的变化,并统计临床治疗效果。结果营养支持后,两组3d及7d后EIN纽与EN组比较CD4＋T细胞及CD4＋／CD8＋比值有显著统计学差异;治疗第7d,EIN组免疫球蛋白Iga、IgG、IgM水平明显高于EN组;治疗结束后,EIN组与EN组术后肛门排气恢复时间、并发症发生率有统计学差畀。结论全胃切除患者应用肠内免疫微生态营养可改善免疫功能,减少感染、手术及死亡的发生率,是一种安全、有效的营养支持方式。     

高渗盐水对重症急性胰腺炎患者血流动力学及血清炎症因子水平的影响

目的 观察高渗盐水对重症急性胰腺炎(SAP)患者的血流动力学及血清炎症因子水平的影响,为临床应用高渗盐水治疗SAP提供理论依据.方法 57例SAP患者完全随机分为对照组(28例)和高渗盐水组(29例).高渗盐水组患者入院后每天按4 ml/kg输入7.5％高渗盐水,对照组患者则在相同时段输入0.9％氯化钠溶液,余治疗相同.分别于入院时及治疗后1、3、7、14 d记录患者平均动脉压(MAP)、HR、中心静脉压(CVP)的变化;酶联免疫吸附法动态检测血清中肿瘤坏死因子α、白细胞介素10浓度,动态比浊法测定血清内毒素含量.结果 治疗后第1天和第7天,高渗盐水组MAP、CVP明显高于对照组[(130±48)mm Hg(1 mm Hg=0.133 kPa)比(104±43)mm Hg,( 129±36) mm Hg比(104±31) mm Hg;(8.39±2.91)cm H2O(1 cm H2O =0.098 kPa)比(5.92±2.84) cm H2O,(8.82±2.69) cm H2O比(6.41±3.10) cmH2O,P＜0.05],而治疗后第3天,高渗盐水组HR明显高于对照组[(98±19)次/min比(126±27)次/min,P＜0.05];治疗后第14天,高渗盐水组内毒素、肿瘤坏死因子-α、白细胞介素-10水平明显低于对照组[(2.70±0.13) ng/L比(3.25±0.30) ng/L,( 30.13±8.12) ng/L比(313.42±144.35) ng/L,( 586.45±14.54) ng/L比(412.72±48.55) ng/L,P＜0.01或P＜0.05].结论 高渗盐水可改善SAP患者的血流动力学状杰并能够抑制全身炎症反应,对SAP的治疗有积极的意义.     

门冬氨酸鸟氨酸对肝切除术后肝功能保护作用的研究

Objective To investigate the protective effects of L-Ornithine-L-Aspartate on liver function in patients after liver resection. Methods Eighty-two patients undergoing liver resection were randomly divided into study group and control group. Control group was treated with conventional therapy and study group had conventional therapy plus L-Ornithine-L-Aspartate for injection intravenously from the first day before operation to the seven day after operation. The fasting alanine aminotransferase (ALT), aspartate aminotransferase ( AST ), γ-glutamyl transpeptadase(GGT), total bilirubin(TB), direct bilirubin(DB) and blood ammonia(BA) levels were determined before operation and on days 1, 3 and 7 after operation. Results On days 1, 3 and 7 after operation, ALT and AST levels in the study group [ALT: ( 115.58 ± 69. 20), (81. 36 ± 14. 55 ), ( 61.24 ± 11. 32) U/L; AST: ( 127.29 ±33.61 ), (95.26 ± 16.83 ), (55.16 ± 14.83 )U/L] were significantly lower than those in the control group[ALT:(175.27 ±68.35), (97.37 ±34.24), (78.28 ± 19. 73) U/L;AST: (152. 29 ±31.65), (115.28 ±35.24),(82.49 ± 28.18) U/L] (P ＜ 0.05 ). In the study group of the porta blocked over 15 min, levels of AST, ALT were obviously lower than that of the control group( P ＜ 0. 05 ). Conclusions L-Ornithine-L-Aspartate for injection can alleviate the hepatic dysfunction after hepatectomy, especially in the long time of porta blocked and has protective advantage for liver function.     

寄生虫性肝脓肿误诊1例

1病历摘要 男,43岁。因反复上腹部疼痛不适2 a余入院。疼痛常在劳累后诱发,发作时感疲倦、乏力,无畏寒、发热。既往有十二指肠球部溃疡病史。查体：消瘦,皮肤巩膜无黄染,腹部无压痛,未触及包块,肝脾未触及。辅助检查：B超示：左肝内叶见一约4.8 cm×3.3 cm、左外叶见一约1.2 cm×1.1 cm低回声团,形态规则,性质待查。CT示：左肝多发低密度结节状影,不除外肝癌。胃镜、肠镜、肝功能、肿瘤指标及肝炎相关检查未见异常。大便未检出虫卵。临床诊断：左肝多发占位（不除外肝癌可能）。     

门冬氨酸鸟氨酸对肝切除术后肝功能保护作用的研究

Objective To investigate the protective effects of L-Ornithine-L-Aspartate on liver function in patients after liver resection. Methods Eighty-two patients undergoing liver resection were randomly divided into study group and control group. Control group was treated with conventional therapy and study group had conventional therapy plus L-Ornithine-L-Aspartate for injection intravenously from the first day before operation to the seven day after operation. The fasting alanine aminotransferase (ALT), aspartate aminotransferase ( AST ), γ-glutamyl transpeptadase(GGT), total bilirubin(TB), direct bilirubin(DB) and blood ammonia(BA) levels were determined before operation and on days 1, 3 and 7 after operation. Results On days 1, 3 and 7 after operation, ALT and AST levels in the study group [ALT: ( 115.58 ± 69. 20), (81. 36 ± 14. 55 ), ( 61.24 ± 11. 32) U/L; AST: ( 127.29 ±33.61 ), (95.26 ± 16.83 ), (55.16 ± 14.83 )U/L] were significantly lower than those in the control group[ALT:(175.27 ±68.35), (97.37 ±34.24), (78.28 ± 19. 73) U/L;AST: (152. 29 ±31.65), (115.28 ±35.24),(82.49 ± 28.18) U/L] (P ＜ 0.05 ). In the study group of the porta blocked over 15 min, levels of AST, ALT were obviously lower than that of the control group( P ＜ 0. 05 ). Conclusions L-Ornithine-L-Aspartate for injection can alleviate the hepatic dysfunction after hepatectomy, especially in the long time of porta blocked and has protective advantage for liver function.